Hitto Kaufmann
Chief Tech/Sci/R&D Officer chez PIERIS PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Postes actifs de Hitto Kaufmann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/08/2019 | - |
| HANSA BIOPHARMA AB | Chief Tech/Sci/R&D Officer | 01/12/2023 | - |
| European Society For Animal Cell Technology | Director/Board Member | - | - |
Pieris Pharmaceuticals GmbH
 Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Part of Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH operates as a German biotechnology company. The private company is based in Hallbergmoos, Germany. The CEOs of the company are Hitto Kaufmann, Stephen S. Yoder. | Chief Executive Officer | - | - |
Historique de carrière de Hitto Kaufmann
Anciens postes connus de Hitto Kaufmann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SANOFI | Chief Operating Officer | 01/01/2018 | 02/01/2019 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - | - |
Formation de Hitto Kaufmann
| The Scripps Research Institute | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
| Technische Universität Braunschweig | Graduate Degree |
Statistiques
Internationale
| Allemagne | 5 |
| Etats-Unis | 4 |
| France | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANOFI | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Part of Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH operates as a German biotechnology company. The private company is based in Hallbergmoos, Germany. The CEOs of the company are Hitto Kaufmann, Stephen S. Yoder. | Health Technology |
| European Society For Animal Cell Technology |
- Bourse
- Insiders
- Hitto Kaufmann
- Expérience
